If you’ve started looking into ketamine therapy for depression, you’ve probably run into a confusing hotchpotch of answers.
One clinic affirms that it’s covered; another says it’s not covered. And your insurer’s own website makes it even more confusing. This has been the case for most people who eventually opt for ketamine therapy. It’s a real quirk in how ketamine therapy insurance coverage actually works. And it comes down to something most people don’t find out until they’re already deep into the process. Not all forms of ketamine therapy are treated the same way by insurers. So, one in-depth understanding becomes necessary if you are opting for ketamine therapy.
Spravato, the FDA-approved nasal spray, is covered by most major insurance plans. The only condition is that a patient should meet criteria for treatment-resistant depression. On the other hand, IV ketamine infusion usually isn’t. Because it’s prescribed off-label. Most insurers exclude it entirely. That single distinction explains most of the confusion you’ve probably already run into.
This piece walks through all the things you need to know about insurance coverage of Ketamine Therapy and what to expect when you are going through the therapy. As always, insurance rules vary by plan and by state. And a clinician or benefits coordinator is the only one who can confirm what your specific policy will actually pay for.
Why Ketamine Therapy Insurance Coverage Is So Inconsistent
The coverage gap comes down to one regulatory fact: Spravato (esketamine) has FDA approval specifically for treatment-resistant depression, while the ketamine used in IV infusions only has FDA approval as an anesthetic – its use for depression is off-label (Ketamine Clinics LA). Insurers build their coverage policies around FDA-approved indications, so a drug with a clear, on-label use for depression gives them something concrete to authorize. A drug being used off-label doesn’t have that same paper trail, even when the clinical evidence supporting it is substantial.
This isn’t unique to ketamine. Roughly a fifth of all U.S. prescriptions are written off-label, and it’s a normal, accepted part of medical practice (Mindbloom). But insurers are inconsistent about which off-label uses they’ll pay for, and depression-related ketamine use tends to fall on the “no” side of that line more often than not.
What’s Typically Covered in the Insurance
Spravato (Esketamine Nasal Spray)
Most national carriers, including major Blue Cross Blue Shield plans, UnitedHealthcare, Aetna, Cigna, and Humana, cover Spravato once a patient documents treatment-resistant depression and clears prior authorization. Medicare Part B also covers it. And many state Medicaid programs do too, though Medicaid coverage varies significantly by state.
Getting to “covered” usually means clearing a few hurdles first:
- Documented history of at least two antidepressants tried at adequate doses without sufficient improvement
- Prior authorization from your insurer, which can take one to four weeks
- Treatment at a REMS-certified provider, since Spravato can only be administered in a certified clinical setting
What Insurance Almost Never Covers
IV ketamine infusion for depression is the clearest coverage gap. Most private insurers, along with Medicare and Medicaid, exclude it because it’s off-label (Moment of Clarity). Intramuscular ketamine and at-home sublingual programs fall into the same category – covered by essentially no one, for the same reason.
There are exceptions worth knowing about, mostly regional. Blue Cross Blue Shield of Massachusetts has a policy that covers IV ketamine for depression using criteria similar to its Spravato policy, and several other Massachusetts payers have followed that lead; Kaiser Permanente in the San Francisco Bay Area offers some coverage as well (Radial). These are exceptions, not the norm – if you’re outside a market where this kind of policy exists, plan on paying out of pocket for IV ketamine.
Coverage Gaps Worth Knowing About
A few gaps catch people off guard even after they’ve confirmed Spravato is “covered”:
- Off-label ketamine for other conditions. Spravato’s approval covers treatment-resistant depression and MDD with acute suicidal ideation – not PTSD, anxiety, or OCD. Off-label use for those conditions follows the same weak coverage pattern as IV ketamine for depression (Innerwell).
- Out-of-network infusion clinics. If you pay upfront at an out-of-network clinic, some insurers will reimburse a portion if you submit a superbill – an itemized receipt with the right diagnosis and procedure codes – but reimbursement isn’t guaranteed and depends entirely on your plan’s out-of-network benefits (Radial).
- Surrounding services. Even when the ketamine itself isn’t covered, related care often is – initial consultations, lab work, and psychotherapy sessions billed separately may qualify for reimbursement when documented as medically necessary (Innerwell).
Mental Health Parity
The Mental Health Parity and Addiction Equity Act says that insurance companies must treat mental health and addiction care the same way they treat physical health care. This means things like copays, deductibles, prior approvals, and visit limits should be similar for both. The law does not require insurance companies to cover every treatment, including off-label treatments like IV ketamine. However, if your insurer makes it harder or more expensive to get mental health treatment than physical health treatment, you have the right to question that decision.
If your insurance claim is denied, you can mention this law in your appeal and include a letter or supporting documents from your doctor. This can make your appeal stronger.
HSA and FSA: An Option Even When Insurance Won’t Pay
This is the detail most people miss. Ketamine therapy ordered by a licensed provider for a diagnosed condition generally qualifies as an HSA- or FSA-eligible medical expense, even when your insurance plan won’t reimburse it directly. The IRS standard for eligibility is whether an expense counts as medical care, not whether the specific treatment carries an FDA indication for your condition. Eligibility details vary by plan administrator. So it’s worth a quick call to confirm before you count on it, and keep your receipts either way.
What to Do Before Your First Appointment
A few concrete steps make the insurance side less of a guessing game:
- Call your insurer directly and ask specifically whether esketamine (Spravato) is in your formulary, and separately, whether IV or IM ketamine for depression is excluded.
- Ask about prior authorization requirements – most plans covering Spravato will want documented proof of at least two prior antidepressant trials.
- Check your Summary of Benefits and Coverage document for out-of-network mental health reimbursement rates, in case you’re considering an infusion clinic.
- Confirm HSA/FSA eligibility with your plan administrator if insurance coverage looks unlikely.
- Keep every document – denial letters, claim numbers, and call notes – in case you need to appeal.
None of this replaces a conversation with your prescribing provider, who can tell you which treatment actually fits your diagnosis and history in the first place – insurance coverage is a real factor, but it shouldn’t be the only one driving the decision. Read more about how Spravato compares to ketamine infusion here if you’re still weighing which option makes sense for you.
Talk to a Provider About Your Coverage Options
If the coverage maze is the thing standing between you and starting treatment, it’s worth a conversation before you rule anything out. Reach out to our team – we can walk through what your specific plan is likely to cover and what the next step looks like.
Frequently Asked Questions
How much does ketamine therapy cost without insurance?
IV ketamine infusions typically run $400 to $1,000 per session out of pocket, with a full course of six to eight infusions totaling roughly $2,400 to $8,000. Spravato without insurance costs more per session upfront – often $1,000 to $1,500+ once monitoring fees are included – but with insurance, that typically drops to a $10 to $25 copay for most covered patients.
Is Spravato covered by insurance?
Yes, for most patients. Current data suggests roughly 95% of patients seeking Spravato have some form of coverage once prior authorization clears, often reducing a $700 to $1,000 retail cost down to a $10 to $25 copay. Medicare Part B also covers it, and many state Medicaid programs do, though state Medicaid coverage varies.
Does Medicare cover ketamine infusion therapy?
Medicare Part A and Part B cover ketamine when it’s used as an anesthetic. For example, during a hospital procedure. But neither covers IV ketamine when it’s used off-label to treat depression. Medicare Part B does cover Spravato for treatment-resistant depression.
Can I use my HSA or FSA for ketamine therapy?
Generally, yes. Ketamine therapy prescribed by a licensed provider for a diagnosed condition typically qualifies as an eligible medical expense under IRS rules, even for off-label use, since the standard is whether it counts as medical care rather than whether it has a specific FDA indication for your diagnosis. Confirm with your plan administrator, since rules can vary slightly by employer plan.
What if my insurance denies coverage for Spravato or ketamine therapy?
You have the right to appeal as it’s legal in all 50 states. The strongest appeals include the specific denial reason, your documented treatment history, and a written rationale from your prescribing clinician explaining medical necessity. You can cite the Mental Health Parity and Addiction Equity Act. If your plan seems to be holding mental health treatment to a stricter standard than comparable physical health treatment, you have the right to appeal.
This article is for informational purposes and isn’t a substitute for medical or financial advice. Contact your insurance provider directly to confirm what your specific plan covers. And talk with a licensed clinician about whether Spravato or ketamine infusion is appropriate for your situation.